Androgen receptor pathway inhibitors and drug–drug interactions in prostate cancer von Bolek, H., Yazgan, S.C., Yekedüz, E., Kaymakcalan, M.D., McKay, R.R., Gillessen, S., Ürün, Y.

Volltext

Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function von Sengul, N., Gültürk, I., Yilmaz, M., Celik, E., Paksoy, N., Yekedüz, E., Ürün, Y., Basaran, M., Özgüroğlu, M.

Volltext

Seguridad y eficacia del nivolumab para el tratamiento de pacientes con carcinoma de células renales metastásico e insuficiencia renal von Sengul, N., Gültürk, I., Yilmaz, M., Celik, E., Paksoy, N., Yekedüz, E., Ürün, Y., Basaran, M., Özgüroğlu, M.

Volltext

P203 A promising biomarker for papillary renal cell carcinoma: Sodium-Glucose cotransporter 2 gene expression (SGLT2) von Akkus, E., Yekedüz, E., Ürün, Y.

Volltext

Colchicine and serum CA72-4 elevation von Gürbüz, M., Tutar, D., Tolunay, P. Kubilay, Karaalioğlu, B., Yekedüz, E., Karaoğlan, M., Utkan, G.

Volltext

OP-40 - Colchicine and serum CA72-4 elevation von Gürbüz, M., Tutar, D., Tolunay, P. Kubilay, Karaalioğlu, B., Yekedüz, E., Karaoğlan, M., Utkan, G.

Volltext

A case with a late recurring limited stage small cell lung cancer von Karaalioglu, B., Utkan, G., Gürbüz, M., Kubilay, P., Yekedüz, E., Büyükkıroğlu, M., Erkuşakçı, C., Aykaç, C., Öztürk, S.

Volltext

PP-99 - A case with a late recurring limited stage small cell lung cancer von Karaalioglu, B., Utkan, G., Gürbüz, M., Kubilay, P., Yekedüz, E., Büyükkıroğlu, M., Erkuşakçı, C., Aykaç, C., Öztürk, S.

Volltext

1794P Prognostic role of metastatic site in patients with de novo metastatic prostate cancer: A population-based analysis in new hormonal agents era von Yekeduz, E., Eid, M., Saad, E., Saliby, R.M., Semaan, K., Gillessen, S., Choueiri, T.K., Urun, Y.

Volltext

1716P Do proton pump inhibitors affect the survival outcomes and safety in colorectal cancer patients treated with regorafenib? A single center and real-life experience von Yekeduz, E., Özyurt, N., Köksoy, E.B., Akbıyık, I., Kalacı, E., Ürün, Y., Utkan, G.

Volltext

1705P Association between baseline radiological tumor burden (BRTB) and outcomes in metastatic clear cell renal cell carcinoma (mccRCC) treated with first line (1L) immunotherapy (... von Nawfal, R., Semaan, K., Eid, M., Paul, M., Saliby, R.M., El Hajj Chehade, R., Machaalani, M., Saad, E., Phillips, N., Canniff, J., Vasseur, D., El Zarif, T., Yekeduz, E., Sun, M., Baca, S., Braun, D.A., Xie, W., Krajewski, K., Choueiri, T.K.

Volltext

176P ERBB2 amplifications across sex, race, and cancer types von Machaalani, M., El Hajj Chehade, R., Nassar, A., El Zarif, T., Saad, E., Yekeduz, E., Saliby, R.M., Steiner, C., Nawfal, R., Semaan, K., Eid, M., Lee, G-S.M., Pomerantz, M., McKay, R.R., Tarantino, P., Braun, D.A., Sun, M., Tolaney, S.M., Choueiri, T.K.

Volltext

99P The association between antibiotic use and survival in renal cell carcinoma patients treated with nivolumab: A multi-center study von Guven, D.C., Acar, R., Yekeduz, E., Bilgetekin, I., Baytemur, N. Kose, Erol, C., Ceylan, F., Sendur, M.A., Demirci, U., Urun, Y., Karadurmus, N., Erman, M., Kilickap, S.

Volltext

Comparison of the Genomic Alterations in Upper-tract and Bladder Urothelial Carcinoma von Yekeduz, E., Saliby, R.M., Shah, V., Baca, S.C., Eid, M., Saad, E., Semaan, K., Bellmunt, J., Choueiri, T.K., Ürün, Y.

Volltext

O09 - Comparison of the Genomic Alterations in Upper-tract and Bladder Urothelial Carcinoma von Yekeduz, E., Saliby, R.M., Shah, V., Baca, S.C., Eid, M., Saad, E., Semaan, K., Bellmunt, J., Choueiri, T.K., Ürün, Y.

Volltext

Supplementary Material for: Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney C... von C., Erol, E., Yekedüz, D., Tural, S., Karakaya, N., ŞentürkÖztaş, G., Uçar, S., Kılıçkap, İ., Ertürk, Ö.N., Sever, Ç., Arslan, A., Küçükarda, O., Can, Ö., Balvan, S.C., Yazgan, M., Özgüroğlu, B., Öksüzoğlu, M.A.N., Şendur, Y., Ürün

Volltext bestellen

Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors von Yekedüz, Emre, Trapani, Dario, Xu, Wenxin, de Vries, Elisabeth G. E., Labaki, Chris, Gyawali, Bishal, Gulati, Shuchi, Nabhan, Chadi, Utkan, Güngör, Curigliano, Giuseppe, Choueiri, Toni K., Ürün, Yüksel

Volltext

Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis von Bakouny, Ziad, Yekedüz, Emre, Braun, David A., Berchuck, Jacob E., Hirsch, Laure, Utkan, Güngör, Lee, Yi, Trinh, Quoc-Dien, Choueiri, Toni K., Ürün, Yüksel

Volltext